INTRODUCTION
High-level resistance to vancomycin and other glycopeptide antibiotics in Enterococcus faecium and E. faecalis with the VanA phenotype results from changes in the peptidoglycanbiosynthetic pathway . Three enzymes are required for resistance, VanA and VanH for synthesis of D-Ala-D-lactate , which is incorporated into peptidoglycan precursors in place of D-Ala-DAla (Messer and Reynolds, 1992; Allen et al., 1992; Handwerger et al., 1992) , and VanX, a dipeptidase which hydrolyses D-Ala-DAla (P. E. Reynolds, F. Depardieu, S. Dutka-Malen, M. Arthur and P. Courvalin, unpublished work), thus decreasing production of the normal peptidoglycan precursor UDP-MurNAc-L-Ala-D-isoGlu-L-Lys-D-Ala-D-Ala (UDP-MurNAc-pentapeptide [Ala] ). A fourth enzyme, the VanY D,D-carboxypeptidase, contributes to glycopeptide resistance by removing D-Ala residues from peptidoglycan precursors (Gutmann et al., 1992; M. Arthur, F. Depardieu, H. A. Snaith, P. E. Reynolds and P. Courvalin, unpublished work) .
Two other species of enterococci which possess the VanC phenotype, E. gallinarum and E. casseliflavus, express constitutive resistance to low levels of vancomycin, but remain sensitive to teicoplanin (Dutka-Malen et al., 1990; Vincent et al., 1991 Vincent et al., , 1992 . The genes encoding resistance are probably chromosomally located, and one of these, vanC, has been identified in E. gailinarum and its sequence has been determined . The vanC gene, specific for E. gallinarum (Leclercq et al., 1992) , is necessary for expression of vancomycin resistance and encodes a protein (VanC) which is related to VanA and to D-Ala-D-Ala ligases of Escherichia coli . Insertional inactivation of vanC in E. gallinarum BM4174 led to the production of the vancomycin- , 1992) .
In this paper we compare the peptidoglycan precursors synthesized in the vancomycin-resistant E. gallinarum BM4174 and its vancomycin-susceptible derivative BM4175 and identify enzyme activities that could be involved in controlling the host glycopeptide-susceptible pathway ofpeptidoglycan synthesis. EXPERIMENTAL Strains and growth conditions E. gallinarum BM4174, constitutively resistant to low levels of vancomycin, and BM4175, in which plasmid pAT217 containing the erythromycin-resistance gene erm had been integrated into vanC , were grown with or without vancomycin (2,g/ml) in brain/heart infusion (BHI) broth supplemented with glucose (1 %, w/v) or on BHI agar at 37 'C. Erythromycin (10 ,ug/ml) was added to the media for BM4175 to maintain the insert in the vanC gene.
Analysis of peptidoglycan precursors
Cultures of E. gallinarum (1.25 litres) were grown to midexponential phase (A600 = 1), ramoplanin (10,ug/ml) was added and incubation continued for 0.66 mean generation time. Bacteria were harvested by centrifugation at 12000 g for 2 min at 4 'C, and low-molecular-mass components in the cytoplasm were extracted with 8 % trichloroacetic acid for 15 min at 4 'C as Abbreviations used: UDP-GIcNAc, UDP-N-acetylglucosamine; UDP-MurNAc, UDP-N-acetylmuramic acid; UDP-MurNAc-tripeptide (UDP-MurNAc-
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described by Messer and Reynolds (1992) . Peptidoglycan precursors were separated by ion-exchange chromatography on Dowex 1 (Cl-form), by a linear chloride gradient (0-0.3 M NaCl in 0.01 M HCl) and desalted by gel filtration on Sephadex G-10. The precursors in the different u.v.-absorbing peaks that reacted positively for N-acetylhexosamine (Strominger, 1957) were identified and assayed in four ways (Messer and Reynolds, 1992) : (i) automated amino acid analysis of samples hydrolysed in 6 M HCI for 4 and 24 h; (ii) determination of amino acids released from UDP-MurNAc-pentapeptide derivatives by the D,D-carboxypeptidase from Actinomadura R39; (iii) mass determination by positive-ion electrospray m.s.; and (iv) h.p.l.c. on a C18 reverse-phase column (Spherisorb-5 ,um, 220 mm x 4.6 mm) eluted with 0.05 M ammonium acetate, pH 5.03, containing a gradient of 0-2 % methanol in 0.05 M ammonium acetate applied between 10 and 20 min.
Preparation of enzyme extracts from E. gallinarum
Strains were grown in BHI/glucose (100 ml) to a turbidity of 1.0 at 600 nm. Bacteria were harvested by centrifugation (30000 g for 30 s at 4°C), washed in buffer A (50 mM Tris/HCl, pH 7.2) and resuspended in 12 ml of the same buffer. The bacteria were lysed by treatment with lysozyme (200 1ug/ml) and Ml muramidase (30,g/ml) at 37 'C. When lysis was almost complete (15 min), MgCl2 (5 mM) and DNAase (20 ,ug/ml) were added and incubation was continued for 5 min at 37 'C. The extracts were centrifuged (48 000 g for 20 min at 4°C) and the supernatant was collected (cytoplasmic fraction). The pellet was washed in buffer A and resuspended in the same buffer at 5 mg ofprotein/ml (membrane fraction).
Assay for D,D-peptidase and D,D-carboxypeptidase
The routine assay contained, in a final volume of 30 ,l, 75 mM Tris/HCl, pH 7.5, 6 mM MgCl2, 1.66 mM substrate (UDPMurNAc-pentapeptide[Ala] for D,D-carboxypeptidase and 1.6 mM D-Ala-D-Ala for D,D-peptidase) and enzyme preparation, diluted to ensure that less than 20% of the substrate was hydrolysed in a 30 min incubation at 37 'C. Benzylpenicillin (250 ,ug/ml) was included in duplicate incubations to investigate its effect on hydrolysis. D-Ala released was assayed by using Damino acid oxidase (Messer and Reynolds, 1992) . D-Serine was assayed by automated amino acid analysis.
RESULTS
Peptidoglycan precursors in E. gallinarum BM4174 and BM4175
Ion-exchange chromatography of the extract from the constitutive vancomycin-resistant E. gallinarum BM4174 that had been incubated in the presence of ramoplanin to inhibit peptidoglycan synthesis gave rise to three peaks of N-acetylhexosamine-containing material (Figure la) . Analysis of Peak 1 indicated that two compounds had co-eluted at a salt concentration of 0.12 M, and these were identified as UDP- The precursors were desalted by gel filtration on Sephadex G-1O before application to the C18 reverse-phase column. The peaks were identified (Table 1) (Table 1 ). The Lys-Asp peptide bond was particularly resistant to acid hydrolysis: only 45 % of these bonds were hydrolysed with 6 M HCl at 105°C for 4 h, and complete hydrolysis required treatment for 30-36 h. The identities of the compounds were confirmed by h.p.l.c. analysis using authentic standards of UDP-MurNAc-tripeptide, UDPMurNAc-tetrapeptide and UDP-MurNAc-pentapeptide[Ala], which were eluted at 10.4, 22.5 and 28.6 min respectively ( Figure  2c ). Under the same conditions UDP-MurNAc-pentapeptide [Ser] was eluted at 23.8 min. Although E. gallinarum BM4174 is constitutively resistant to vancomycin, growth of the organism in BHI/glucose containing a sub-inhibitory concentration of the antibiotic (2 ,ug/ml), but without the addition of ramoplanin, also resulted in the accumulation of the cell-wall precursors UDP-MurNAc-tetrapeptide and UDP-MurNAc-pentapeptide- [Ser] . This indicates that peptidoglycan synthesis had been partially inhibited at sub-inhibitory concentrations of the antibiotic, although the amounts of the precursors that accumulated were much lower than those obtained after inhibition of pep- (Table 2) . Extracts of E. gallinarum BM4175 contained very low levels of activity against either substrate, indicating that inactivation of the vanC gene had also prevented expression of the genes encoding the D,D-peptidase and D,Dcarboxypeptidase activities (Table 2) . The residual low level of D,D-carboxypeptidase activity present in membrane preparations from this strain was inhibited by benzylpenicillin, indicating that it was probably catalysed by a low-molecular-mass penicillinbinding protein.
The activity of the cytoplasmic extract of E. gallinarum BM4174 against UDP-MurNAc-pentapeptide [Ser] was at most 2-3 % of the activity against UDP-MurNAc-pentapeptide [Ala] . Therefore the D,D-carboxypeptidase removes the cell-wall precursor involved in the vancomycin-susceptible pathway of peptidoglycan synthesis, but has little effect on the resistant pathway. (Bugg et al., 1991) . The replacement of a D-alanine residue by D-serine should not affect the number of hydrogen bonds that can be formed between vancomycin and the altered precursor, but the binding affinity will be altered. The binding pocket in vancomycin is very specific (Barna and Williams, 1984) , and the affinity for the target is greatest when the R group of the terminal residue is a methyl group (Nieto and Perkins, 1971 
